Research purposes only.
All our research peptides come in lyphollized/powder form and must be reconstituted to a liquid for researching and testing.
3rd party tested for purity.
PT-141, also known as bremelanotide, is a synthetic peptide primarily used for treating hypoactive sexual desire disorder (HSDD) in premenopausal women. Derived from the melanocortin peptide family, it is unlike traditional sexual dysfunction treatments that act on the vascular system (like Vi@gr@).
PT-141 works by activating melanocortin receptors in the brain, particularly MC3R and MC4R, which are involved in sexual arousal.